OVALEAP

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
OVALEAP

ACTIVE PRINCIPLE
FOLLITROPIN ALFA

TYPE OF DEVICE
INJECTABLE SOLUTION WITH PEN

LATEX
DO NOT

TEMPERING TIME
No information

START OF INJECTION
Inserting the needle into the skin

CLICK TO THE START (IN PEN)
No

CLICK AT THE END (IN PEN)
No

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

PRIVACY POLICY

SUBSCRIBE